Hospital General Universitario Gregorio Marañón

Madrid, Madrid 28007

3 studies enrolling now · 7 studies all time

What they study most

Advanced Melanoma, Advanced Solid Tumor, Chronic Primary Immune Thrombocytopenia (ITP), Hepatocellular Carcinoma, NASH - Nonalcoholic Steatohepatitis, Relapsed Small Cell Lung Cancer, Venous Thromboembolism

Studies at this site

• A Study Investigating Intravenous Human Normal Immunoglobulin 10% in Adults With Chronic Immune Thrombocytopenia (ITP) — Recruiting now
• Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma. — Recruiting now
• Computerized Registry of Patients With Venous Thromboembolism (RIETE) — Recruiting now
• Clinical Trial of Lurbinectedin as Single-agent or in Combination With Irinotecan Versus Topotecan or Irinotecan in Patients With Relapsed Small-cell Lung Cancer (LAGOON) — Completed
• A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 ) — Running, not enrolling
• PM14 Administered Intravenously to Patients With Advanced Solid Tumors — Completed
• A Trial of Lenvatinib Plus Pembrolizumab in Participants With Hepatocellular Carcinoma — Completed